{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "position" : "Tyr105",
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P14618",
      "entity_text" : "PKM2",
      "entity_type" : "protein"
    },
    "is_direct" : true,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P16070",
      "entity_text" : "CD44",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Unlike the other PKM2 interactors HPV16-E7, which inhibits PKM2 tetramerization by acetylating PKM2 at K433 XREF_BIBR, and CD44, which inhibits PKM2 tetramerization by phosphorylating PKM2 at Tyr105 XREF_BIBR, TBC1D8 does not change the acetylation or phosphorylation levels of PKM2.",
  "reading_complete" : "2020-08-03T09:21:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:19:23Z",
  "evidence" : [ "CD44, which inhibits PKM2 tetramerization by phosphorylating PKM2 at Tyr105" ],
  "pmc_id" : "6376479",
  "score" : 0
}